These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9605992)

  • 21. Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.
    Proost P; Struyf S; Schols D; Opdenakker G; Sozzani S; Allavena P; Mantovani A; Augustyns K; Bal G; Haemers A; Lambeir AM; Scharpé S; Van Damme J; De Meester I
    J Biol Chem; 1999 Feb; 274(7):3988-93. PubMed ID: 9933589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human immunodeficiency virus type 1 infection in a T-cell line (CEM) by new dipeptidyl-peptidase IV (CD26) inhibitors.
    Jiang JD; Wilk S; Li J; Zhang H; Bekesi JG
    Res Virol; 1997; 148(4):255-66. PubMed ID: 9272576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients.
    Uematsu T; Urade M; Yamaoka M; Yoshioka W
    J Oral Pathol Med; 1996 Oct; 25(9):507-12. PubMed ID: 8959560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.
    Cordero OJ; Varela-Calviño R; López-González T; Calviño-Sampedro C; Viñuela JE; Mouriño C; Hernández-Rodríguez Í; Rodríguez-López M; Aspe de la Iglesia B; Pego-Reigosa JM
    PLoS One; 2015; 10(7):e0131992. PubMed ID: 26177310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD26 expression is down-regulated on CD8
    Liu Y; Li Y; Gong Y; Yu N; Zhang Y; You R; Qu C; Lu G; Huang Y; Gao Y; Gao Y; Guo X
    Int Immunopharmacol; 2018 Jan; 54():280-285. PubMed ID: 29175506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD26 and DPP IV expression in T acute lymphoblastic leukemia cells: immunocytochemistry and enzyme cytochemistry.
    Klobusická M; Babusíková O
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():34-7. PubMed ID: 10707830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is CD26/dipeptidyl peptidase IV a really important molecule in T cell activation of a certain rat strain?
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Immunobiology; 1995 Nov; 194(4-5):429-42. PubMed ID: 8749235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cDNA cloning for mouse thymocyte-activating molecule. A multifunctional ecto-dipeptidyl peptidase IV (CD26) included in a subgroup of serine proteases.
    Marguet D; Bernard AM; Vivier I; Darmoul D; Naquet P; Pierres M
    J Biol Chem; 1992 Feb; 267(4):2200-8. PubMed ID: 1370813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of dipeptidyl-peptidase IV (CD26) on CD8+ T cells is significantly decreased in patients with psoriasis vulgaris and atopic dermatitis.
    Bock O; Kreiselmeyer I; Mrowietz U
    Exp Dermatol; 2001 Dec; 10(6):414-9. PubMed ID: 11737260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD26/DPP IV in experimental and clinical organ transplantation.
    Korom S; de Meester I; Belyaev A; Schmidbauer G; Schwemmle K
    Adv Exp Med Biol; 2003; 524():133-43. PubMed ID: 12675233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Costimulation of CD4+ and CD8+ T cells through CD26: the ADA-binding epitope is not essential for complete signaling.
    De Meester IA; Kestens LL; Vanham GL; Vanhoof GC; Vingerhoets JH; Gigase PL; Scharpé SL
    J Leukoc Biol; 1995 Sep; 58(3):325-30. PubMed ID: 7665988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Murine thymocytes possess specific cell surface-associated exoaminopeptidase activities: preferential expression by immature CD4-CD8- subpopulation.
    Bauvois B
    Eur J Immunol; 1990 Mar; 20(3):459-68. PubMed ID: 2108042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of Dipeptidyl Peptidase-IV/CD26 and Aminopeptidase N/CD13 in Secretome of Mesenchymal Stem Cells after Treatment with LPS and PMA.
    Ramezani Ali Akbari K; Fathollahi A; Hashemi SM; Pouriran R; Yeganeh F
    Iran J Immunol; 2020 Mar; 17(1):41-51. PubMed ID: 32224540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo inhibition of dipeptidyl peptidase IV activity by pro-pro-diphenyl-phosphonate (Prodipine).
    De Meester I; Belyaev A; Lambeir AM; De Meyer GR; Van Osselaer N; Haemers A; Scharpé S
    Biochem Pharmacol; 1997 Jul; 54(1):173-9. PubMed ID: 9296364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties.
    Proost P; Schutyser E; Menten P; Struyf S; Wuyts A; Opdenakker G; Detheux M; Parmentier M; Durinx C; Lambeir AM; Neyts J; Liekens S; Maudgal PC; Billiau A; Van Damme J
    Blood; 2001 Dec; 98(13):3554-61. PubMed ID: 11739156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.